Rx Rundown: Flagship Pioneering, Grifols, Element Biosciences and more
Deals: The Grifols family and Canadian fund Brookfield agreed to launch a joint takeover bid for Spanish drugmaker Grifols with the intent to delist it. Ligand plans to buy Apeiron Biologics for $100 million. Johnson & Johnson settled with Emergent …